Connect with us

Technology

TAT Technologies Reports Record Second Quarter 2026 Results

Published

on

Revenue Increases 22.8% as Demand Remains Strong and Supply Chain Conditions Ease; Backlog and Long-Term Agreements Reach Record $615 Million 

CHARLOTTE, N.C., Aug. 5, 2026 /PRNewswire/ — TAT Technologies Ltd. (NASDAQ: TATT) (TASE: TAT Tech), a leading supplier of products and services for the commercial and military aerospace and ground defense industries, today reported financial results for the second quarter ended June 30, 2026.

Financial highlights:

Revenues were $52.9 million, a 22.8% increase compared to $43.1 million in the second quarter of 2025. For the first half of 2026, revenues increased by 10.4% to $94.1 million compared to $85.2 million in the first half of 2025.Gross profit increased by 23.0% to $13.3 million, representing 25.2% of revenues, compared to $10.8 million (25.1% of revenues) in the second quarter of 2025. For the first half of 2026, gross profit increased by 12.4% to $23.4 million compared to $20.8 million in the first half of 2025 (24.8% of revenues in the first half of 2026 compared to 24.4% of revenues in the first half of 2025).Operating Income increased by 26.8% to $5.6 million (10.6% of revenues) compared to $4.4 million (10.3% of revenues) for Q2 2025. For the first half of 2026, operating income was $8.6 million (9.1% of revenues) compared to $8.6 million (10.1% of revenues) in the first half of 2025Net Income of $8.1 million (Diluted EPS of $0.61) compared to $3.4 million for Q2 2025 (Diluted EPS of $0.3). The second quarter of 2026 included a $4.3 million (Diluted EPS of $0.26) net of tax, non-operating gain from the sale of a minority interest in an unconsolidated entity. Excluding the non-recurring benefit, net income would have been $4.66 million, an increase of 35.2% compared to the previous period (and Adjusted Diluted EPS of $0.35). For the first six months of the year, net profit was $11.5 (Diluted EPS of $0.87) million. Excluding the one-time net impact of the minority interest sale, net profit for the first six months was $8.06 million, an increase of 11.0% compared to $7.3 million in the previous period.Adjusted EBITDA was $7.4 million (14.0% of revenues), a 22.7% increase from $6.1 million (14.0% of revenues) for Q2 2025. Adjusted EBITDA for the first half of 2026 increased by 4.1% to $12.3 million (13.1% of revenues) compared to $11.8 million (13.8% of revenues) in the first half of 2025.Cash flow used in operations for the second quarter was $(0.6) million compared to $6.9 million provided by operations in Q2 2025. Cash flow from operations was $1.4 million in the first half of 2026 compared to $1.9 million in the first half of 2025.Backlog and Long-Term Agreements: approximately $615 million as of June 30, 2026, up from approximately $580 million on March 31, 2026, reflecting continued strong customer demand and providing multi-year revenue visibility.

“Continued strong demand and solid execution drove nearly 23% revenue growth and continued profitability improvements,” said Igal Zamir, TAT’s CEO and President. “This performance reflects our strategic position in the market, targeting high-demand services backed by established and solid relationships with OEMs. In part, improving supply chain conditions enabled us to convert previously constrained customer demand into revenue in the quarter, further enhancing results. Demand across our end markets remains robust and customer loyalty remained strong despite the supply chain shortages, driving backlog and long-term agreements to the highest in company history. Although supply chain conditions have not fully normalized, we remain focused on securing the components our customers need, reinforcing our position as a trusted aftermarket partner and supporting long-term profitable growth.”

“We have expanded our strategic relationship with Honeywell Aerospace” Zamir continued. “We became the sole authorized distributor(*) of spare parts for the 331-200 auxiliary power unit platform (APU), extended our MRO license through 2036, and acquired three Honeywell Aerospace 131-9A APUs to expand our leasing business. These agreements strengthen our position in the APU aftermarket and ensure that we will continue to be a valued partner for Honeywell for a long time to come.”

“We believe the combination of historically high customer demand, expanding platform coverage, and a record backlog, combined with improving supply chain conditions, positions TAT well for continued profitable growth,” Concluded Zamir.

(*) As previously disclosed in the Company’s Report on Form 6-K filed on July 14, 2026.

Investor Call Information

TAT Technologies will host an earnings webcast and conference call today, August 5, 2026, at 8:00 a.m. Eastern Time to discuss second quarter results. Investors may register using the link below or by visiting the Company’s website.

Webcast Registration: https://us06web.zoom.us/webinar/register/WN_MRtan_3wQoG9XfDYLkuNeA

Investor Relations Website: https://tat-technologies.com/investors/

Non-GAAP Financial Measures

To supplement its GAAP results, the Company presents Adjusted EBITDA to provide investors with additional insight into underlying operating performance. Adjusted EBITDA excludes the Company’s share in results of affiliated companies, share-based compensation, income taxes, net financial (expenses) income, and depreciation and amortization. Adjusted EBITDA should not be considered as an alternative to net income and operating income for the period and may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles and may not be comparable to other similarly titled measures for other companies. See reconciliation of Adjusted EBITDA below.

About TAT Technologies

TAT Technologies Ltd. (NASDAQ: TATT) (TASE: TAT Tech) is a leading provider of services and products to the commercial and military aerospace and ground defense industries, providing OEM heat transfer solutions and aviation accessories, MRO services for aviation components, including heat transfer solutions, overhaul and coating of jet engine components, including turbine vanes and blades, fan blades, variable inlet guide vanes and afterburner flaps and MRO services on APU’s, landing gears and other aircraft components for airlines, air cargo carriers, maintenance service centers and the military. For more information, please visit www.tat-technologies.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the United States federal securities laws. These forward-looking statements include, without limitation, statements regarding possible or assumed future operating results, demand conditions, supply chain conditions, customer relationships, backlog conversion, market position, and growth prospects. These statements are hereby identified as “forward-looking statements” for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties that could cause our results to differ materially from management’s current expectations. Actual results and performance can also be influenced by other risks that we face in running our operations, including, but not limited to, general business conditions in the airline industry, changes in demand for our services and products, the timing and amount or cancellation of orders, LTAs and backlog, the price and continuity of supply of component parts used in our operations, the war and hostilities between Israel and Hamas, Hezbollah and Iran, regional shipping disruptions and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission, including its Annual Report on Form 20-F and its periodic reports on Form 6-K. These documents contain and identify other important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements. Shareholders and other readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. The Company undertakes no obligation to update publicly or revise any forward-looking statement.

Contact:

Eran Yunger
Director of IR
Tel: +1-980-451-1115
erany@tat-technologies.com

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

TAT TECHNOLOGIES LTD.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS 

U.S dollars in thousands

June 30,

December 31,

2026

2025

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$54,629

$51,259

Accounts receivable, net of allowance for credit losses of $228
and $172 as of June 30, 2026, and December 31, 2025,
respectively 

 

38,813

 

33,420

Inventory

85,189

75,549

Prepaid expenses and other current assets

7,041

6,071

Total current assets

185,672

166,299

NON-CURRENT ASSETS:

Property, plant and equipment, net

47,001

46,922

Operating lease right of use assets

5,285

5,807

Intangible assets, net

1,884

1,452

Investment in affiliates

5,726

4,905

Funds in respect of employee rights upon retirement

446

398

Deferred tax assets

573

639

Restricted deposit

307

Total non-current assets

60,915

60,430

Total assets

$246,587

$226,729

 

 

TAT TECHNOLOGIES LTD.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS  

U.S dollars in thousands

June 30,

December 31,

2026

2025

LIABILITIES AND SHAREHOLDERS’ EQUITY

CURRENT LIABILITIES:

Current maturities of long-term debts

$164

$2,227

Accounts payable

18,531

12,986

Accrued expenses and other current liabilities

18,309

17,296

Current maturities of operating lease liabilities

1,459

1,474

Total current liabilities

38,463

33,983

NON-CURRENT LIABILITIES:

    Long-term debts, net

11,018

9,485

Operating lease liabilities

4,032

4,448

Liability in respect of employee rights upon retirement

853

770

Deferred tax liabilities

3,286

1,652

 Total non-current liabilities

19,189

16,355

COMMITMENTS AND CONTINGENCIES (NOTE 7)                                                

Total liabilities

57,652

50,338

 

SHAREHOLDERS’ EQUITY:

Ordinary shares of NIS 0 par value

Authorized: 19,000,000 shares at June 30, 2026, and at December 31, 2025

Issued:13,272,610 shares at June 30, 2026, and 13,257,610 shares at December
31, 2025 

Outstanding: 12,998,137 shares at June 30, 2026, and 12,983,137 shares
at December 31, 2025

Additional paid-in capital

137,567

136,578

Treasury stock at cost

(2,088)

(2,088)

Accumulated other comprehensive income

727

643

Retained earnings

52,729

41,258

Total shareholders’ equity

188,935

176,391

Total liabilities and shareholders’ equity

$246,587

$226,729

 

 

TAT TECHNOLOGIES LTD. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME

U.S dollars in thousands

Three Months Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Revenues:

Products

$15,329

$12,463

$29,235

$25,187

Services

37,609

30,641

64,850

60,059

52,938

43,104

94,085

85,246

Costs:

Products

10,775

9,112

20,874

17,443

Services

28,843

23,167

49,860

47,024

39,618

32,279

70,734

64,467

Gross profit

13,320

10,825

23,351

20,779

Operating expenses:

Research and development, net

535

240

1,106

564

Selling and marketing

2,530

2,185

4,712

4,113

General and administrative

4,632

3,965

8,925

7,497

7,697

6,390

14,743

12,174

Operating income

5,623

4,435

8,608

8,605

Gain on sale of equity investment

4,324

4,324

Interest expenses

(182)

(324)

(330)

(659)

Other financial expenses, net

(368)

(776)

(181)

(499)

Income before taxes on income

9,397

3,335

12,421

7,447

Provision for income taxes

1,911

211

2,056

803

Income before share of equity investment

7,486

3,124

10,365

6,644

Share in profits of equity investment
of affiliated companies

585

318

1,106

611

Net income

$8,071

$3,442

$11,471

$7,255

 

 

TAT TECHNOLOGIES LTD.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

U.S dollars in thousands, except share and per share data 

Three Months Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Earnings per share

Basic

$0.62

$ 0.30

$0.88

$ 0.65

Diluted

$0.61

$ 0.30

$0.87

$ 0.64

Weighted average number of shares
outstanding

Basic

12,987,471

11,447,986

12,985,316

11,196,992

Diluted

13,131,610

11,666,309

13,164,168

11,409,488

 

TAT TECHNOLOGIES LTD. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 

U.S dollars in thousands

Three Months Ended

 June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Net income

$8,071

$3,442

$11,471

$7,255

Other comprehensive income (loss), net:

Change in foreign currency translation adjustments

(100)

148

91

676

Net unrealized losses from derivatives

(7)

(7)

        Total comprehensive income

$7,964

$3,590

$11,555

$7,931

 

TAT TECHNOLOGIES LTD. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY 

U.S dollars in thousands, except share data 

Share capital

Accumulated

Number of
shares issued

Amount

Additional
paid-in
capital

other 
comprehensive
income

Treasury shares

Retained earnings

Total equity

BALANCE AT MARCH 31, 2025

11,214,831

$-

$89,919

$452

$(2,088)

$28,249

$116,532

CHANGES DURING THE THREE MONTHS ENDED JUNE 30, 2025:

Comprehensive income

148

3,442

3,590

Exercise of stock option

79,633

Issuance of common shares on public offering, net of issuance costs of
$2,769

1,625,000

39,415

39,415

Exercise of the underwriters’ option on public offering, net of issuance
costs of $413

242,298

5,953

5,953

Share based compensation

291

291

BALANCE AT JUNE 30, 2025 

13,161,762

$ –

$135,578

$600

$(2,088)

$31,691

$165,781

BALANCE AT MARCH 31, 2026

13,257,610

$-

$137,071

$834

$(2,088)

$44,658

$180,475

CHANGES DURING THE THREE MONTHS ENDED JUNE 30, 2026:

Comprehensive income

(107)

8,071

7,964

Exercise of stock option

15,000

136

136

Share based compensation

360

360

BALANCE AT JUNE 30, 2026

13,272,610

$-

$137,567

$727

$(2,088)

$52,729

$188,935

 

TAT TECHNOLOGIES LTD. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY 

U.S dollars in thousands, except share data 

Share capital

Accumulated

Number of
shares issued

Amount

Additional
paid-in
capital

other
comprehensive
income (loss)

Treasury shares

Retained earnings

Total equity

BALANCE AT DECEMBER 31, 2024 

11,214,831

$-

$89,697

$(76)

$(2,088)

$24,436

$111,969

CHANGES DURING THE SIX MONTHS ENDED JUNE 30, 2025:

Comprehensive income

676

7,255

7,931

Exercise of option

79,633

Issuance of common shares on public offering, net of issuance costs of
$2,769

1,625,000

39,415

39,415

Exercise of the underwriters’ option on public offering, net of issuance
costs of $413

242,298

5,953

5,953

Share based compensation

513

513

BALANCE AT JUNE 30, 2025

13,161,762

$-

$135,578

$600

$(2,088)

$31,691

$165,781

BALANCE AT DECEMBER 31, 2025

13,257,610

$-

$136,578

$643

$(2,088)

$41,258

$176,391

CHANGES DURING THE SIX MONTHS ENDED JUNE 30, 2026:

Comprehensive income

84

11,471

11,555

Exercise of option

15,000

136

136

Share based compensation

853

853

BALANCE AT JUNE 30, 2026

13,272,610

$-

$137,567

$727

$(2,088)

$52,729

$188,935

 

TAT TECHNOLOGIES LTD. 

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 

U.S. dollars in thousands

Three Months Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income 

$8,071

$3,442

$11,471

$7,255

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

1,391

1,208

2,704

2,513

Non-cash financial expenses

21

600

352

508

Gain on sale of equity investment (Note 4)

(4,324)

(4,324)

Change in allowance for credit losses

(14)

75

55

25

Share in profits of equity investment of affiliated companies

(585)

(318)

(1,106)

(611)

Share based compensation

360

291

853

513

Deferred income taxes, net

1,615

63

1,700

582

Changes in operating assets and liabilities:

Decrease (increase) in trade accounts receivable

(8,342)

882

(5,448)

(2,594)

Increase in inventory

(3,453)

(3,434)

(9,883)

(7,295)

Decrease (increase) in prepaid expenses and other current assets

1,445

1,697

(812)

1,183

Increase in trade accounts payable

2,403

2,972

4,874

3,406

Increase (decrease) in accrued expenses and other current liabilities

850

(529)

952

(3,571)

Net cash provided by (used in) operating activities

(562)

6,949

1,388

1,914

CASH FLOWS FROM INVESTING ACTIVITIES:

Proceeds from sale of equity investment

4,493

4,493

Purchase of property and equipment

(1,139)

(3,305)

(2,559)

(6,167)

Net cash provided by (used in) investing activities

3,354

(3,305)

1,934

(6,167)

CASH FLOWS FROM FINANCING ACTIVITIES:

Repayment of short-term debts

(10,719)

(4,350)

Repayments of long-term debts

(10,721)

(516)

(11,272)

(1,087)

Proceeds from issuance of ordinary shares and exercise of the underwriters’ option

48,550

48,550

Issuance costs of ordinary shares and exercise of the underwriters’ option

(2,820)

(2,820)

Proceeds from long term debt, net

10,877

10,877

Proceeds from exercise of options

136

136

Net cash provided by (used in) financing activities

292

34,495

(259)

40,293

Net increase in cash and cash equivalents and restricted cash

3,084

38,139

3,063

36,040

Cash and cash equivalents and restricted cash at beginning of period

51,545

5,335

51,566

7,434

Cash and cash equivalents and restricted cash at the end of period

$54,629

$43,474

$54,629

$43,474

Supplementary information on investing and financing activities not involving cash flows:

   Additions of operating lease right-of-use assets and operating lease liabilities

$217

$1,688

$299

$1,835

   Reclassification between inventory and property, plant and equipment

579

   Unpaid issuance costs on long term debt and issuance of shares

152

362

152

362

   Unpaid addition to property and equipment and intangible assets

1,140

951

1,140

951

Supplemental disclosure of cash flow information:

   Interest paid

154

249

303

516

   Taxes paid

79

176

192

195

 

 RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP)  (UNAUDITED)

 

TAT TECHNOLOGIES LTD.

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA (NON-GAAP)  (UNAUDITED)

U.S dollars in thousands

Three months ended

Six months ended

June 30,

June 30,

2026

2025

2026

2025

Net income

$8,071

$3,442

$11,471

$7,255

Adjustments:

Share in profits of equity investment of affiliated companies

(585)

(318)

(1,106)

(611)

Provision for income taxes

1,911

211

2,056

803

Interest expenses

182

324

330

659

Gain on sale of equity investment

(4,324)

(4,324)

Other financial expenses, net

368

776

181

499

Depreciation, amortization and others

1,445

1,328

2,820

2,691

Share based compensation

360

291

853

513

Adjusted EBITDA

$7,428

$6,054

$12,281

$11,809

 

 

TAT TECHNOLOGIES LTD.

ADJUSTED NET INCOME ATTRIBUTABLE TO TAT TECHNOLOGIES LTD.  (UNAUDITED)

U.S. dollars in thousands

Three months ended

Six months ended

June 30,

June 30,

2026

2025

2026

2025

Net income

$8,071

$3,442

$11,471

$7,255

Adjustments:

Gain on sale of equity investment

(4,324)

(4,324)

Income tax impact

908

908

Adjusted net income

$4,655

$3,442

$8,055

$7,255

 

Earnings per share

Basic                                                           

$0.62

$ 0.30

$0.88

$ 0.65

Diluted

$0.61

$ 0.30

$0.87

$ 0.64

Adjusted earnings per share                     

Basic

$0.36

$ 0.30

$0.62

$ 0.65

Diluted

$0.35

$ 0.30

$0.61

$ 0.64

 

 

View original content:https://www.prnewswire.com/news-releases/tat-technologies-reports-record-second-quarter-2026-results-302843077.html

SOURCE TAT Technologies Ltd

Continue Reading

Technology

UK digital pathology provider Source BioScience chooses Sectra to enable seamless pathology collaboration across the NHS

Published

on

By

LINKÖPING, Sweden, Sept. 21, 2026 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed an agreement with Source BioScience UK Ltd (Source BioScience) in the UK to deliver its service for advanced share and collaborate workflows. As the first Sectra customer in this domain, Source BioScience will now be able to support NHS organisations that need to send pathology cases to external specialists. This lays the foundation for national telepathology networks in the UK, and for improved access to specialist pathologists.

The service, Sectra Image Exchange Portal (Sectra IEP), is a cloud-based, vendor-neutral platform for exchanging and collaborating around medical images. It is already used by more than 500 institutions, mainly within radiology. Recently, the service has undergone substantial modernisation which now makes it possible for healthcare providers to benefit from new advanced workflow functionality, for the service to be used by specialties other than radiology and for customers to move beyond image sharing to managing workflows between organisations.

“This milestone integration will give the NHS a seamless digital pathway to external specialists, with diagnoses delivered straight back into its own records – reducing turnaround times, easing consultant shortages and tackling reporting backlogs,” says Nick Bills, Healthcare Director at Source BioScience.

Source BioScience is a UK laboratory services provider specialising in histopathology and genomics. Its pathology business supports more than 85 NHS trusts alongside a network of private healthcare clinics, with histopathology delivered from laboratories in Nottingham, Chichester and Cambridge.

NHS pathology services are handling growing case volumes with a limited number of reporting consultants, and increasing subspecialisation means the pathologist best suited to a case is often at another organisation. Sending work to external capacity providers today typically relies on bespoke arrangements between individual laboratories, including the transportation of physical glass slides. This slows reporting times and creates administrative overhead for both the sending and receiving laboratories. With Sectra’s service, a case can be created as a job directly from a laboratory’s worklist, delegated to a receiving organisation, and the completed report returned to the referring organisation’s own records.

“IEP is the backbone of image sharing across the NHS. With our modernised platform, we are introducing advanced workflows between healthcare organisations, and extending that trusted national network into pathology. Connecting trusts directly with external specialists like Source BioScience means cases and completed reports move seamlessly across organisational boundaries. It is a step towards an NHS where expertise is always within reach, and where work moves between organisations as easily as it moves within them,” says Jane Rendall, Managing Director for Sectra UK and Ireland.

The three-year contract was signed in the second quarter of Sectra’s 2026/2027 fiscal year. Up to 60,000 cases are expected during the first year, scaling up in subsequent years.

Source BioScience Media Contact:
Klaudyna Johnstone, Commercial Director, klaudyna.johnstone@sourcebioscience.com 

CONTACT:

For further information, please contact: Dr. Torbjörn Kronander, CEO and President Sectra  AB, 46 (0) 705 23 52 27
Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, 46 (0)708 23 56 10

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/uk-digital-pathology-provider-source-bioscience-chooses-sectra-to-enable-seamless-pathology-collabor,c4398521

The following files are available for download:

 

 

View original content:https://www.prnewswire.co.uk/news-releases/uk-digital-pathology-provider-source-bioscience-chooses-sectra-to-enable-seamless-pathology-collaboration-across-the-nhs-302884440.html

Continue Reading

Technology

askelie® opens its Operational AI Platform to customers and partners

Published

on

By

New platform makes proven AI capabilities available for MSPs, software vendors and business users to configure and compose

LONDON, Sept. 21, 2026 /PRNewswire/ — askelie® today announced the launch of its Operational AI Platform, opening the proven technology behind its enterprise AI solutions to MSPs, software vendors and business users.

The platform enables customers and partners to configure and compose AI-powered solutions using proven, reusable askelie capabilities. Rather than building an AI foundation from scratch, organisations can combine existing capabilities to address real business needs — providing a practical route from AI ambition to business value, with faster time to value, lower cost and less risk.

“We’ve spent years using askelie to rapidly deliver enterprise-grade AI solutions. What we’re doing now is opening that capability up,” said Derek Kilroe, CEO and Founder, askelie. “For the first time, MSPs, software vendors and business users can take proven AI capabilities and configure and compose their own solutions for real business operations — without having to build the underlying AI platform themselves.”

Built around Understand • Decide • Act • Control, the platform brings together AI intelligence, data, knowledge, workflows, enterprise integrations, security and governance.

At launch, customers and partners can configure and compose existing capabilities to create and adapt AI-powered Assistants and Automations around specific business needs. The platform provides the foundation for increasingly sophisticated AI applications, including Digital Workers and Autonomous Applications.

“Customers shouldn’t have to assemble an AI technology stack before they can solve a business problem,” said Ian Halliday-Pegg, Chief Product Officer, askelie. “askelie brings the capabilities needed for operational AI together in a platform that can be combined and reused for different needs.”

The platform is designed to be practical, affordable and trusted. Proven, reusable capabilities reduce the need to build enterprise AI from scratch; model choice and consumption-based pricing help control costs; and security, governance, human oversight and auditability are built into the platform.

The platform also enables MSPs to configure and reuse AI-powered services across customers, while software vendors can extend existing products, enhance them with external data and context, and configure new AI-powered capabilities.

The askelie Operational AI Platform is available from 21 September 2026.

For more information, visit www.askelie.io

View original content to download multimedia:https://www.prnewswire.com/news-releases/askelie-opens-its-operational-ai-platform-to-customers-and-partners-302884442.html

SOURCE AskELIE Limited

Continue Reading

Technology

Huawei Upgrades Stellar AI WAN Solution to Drive All Intelligence Across Industries

Published

on

By

SHANGHAI, Sept. 21, 2026 /PRNewswire/ — At HUAWEI CONNECT 2026, Huawei unveiled its upgraded Stellar AI WAN Solution. Centered on ultimate computing efficiency and multi-dimensional security, this solution addresses cross-region computing challenges in efficiency, cost, and security, driving all intelligence across industries in the AI era.

Stellar AI WAN for Intelligent Connectivity

Amid the rapid expansion of AI computing power, deploying new compute infrastructure in the West has made remote invocation the new norm. However, traditional networks face three critical issues relating to cross-region computing.

Severe efficiency loss: Invoking computing power across 1,000 km can incur a 37% efficiency loss from a mere 0.073% packet loss.High on-premise costs: Local compute deployment costs from 1 million RMB per branch.Expensive private lines: Enterprises spend around 1.2 million RMB annually on 10G private lines.

To address this, Leon Wang, President of Huawei’s Data Communication Product Line, introduced the Stellar AI WAN Solution, enabling lossless delivery of computing power over 1,000 km for a local-like remote computing experience. The XH computing-network appliance uses a unique layerwise model partitioning algorithm to run the initial and final layers of inference locally while offloading intermediate layers to remote infrastructure. With the network transmitting only high-dimensional vectors, raw data remains on-premises. The appliance requires just two xPUs to match a traditional 8-xPU setup, slashing xPU costs by 75%. The updated Starnet lossless algorithm cuts bandwidth idle time by over 80% and reduces required bandwidth fivefold, further lowering cross-region computing costs.

Stellar AI WAN for Security

As global security threats intensify, novel vectors like APTs and HNDL attacks continue to emerge. To address these, Huawei provides a three-layer defense for WANs.

Device layer: Intrinsic security boards detect and block intrusions in real time, tracing threats within minutes at over 95% accuracy.Link layer: Built-in QKD delivers robust quantum security without extra devices or fibers, slashing costs by over 60%. An adaptive noise suppression algorithm extends QKD transmission past 80 km.Network layer: APN6-based data fencing enables network-wide control over traffic paths, ensuring data travels exclusively within secure networks with intrinsic security and quantum encryption deployed.

Looking ahead, Huawei will continually upgrade the Stellar AI WAN Solution, deepening its computing-network synergy and multi-dimensional security. Together with partners, Huawei aims to reinforce the intelligent network foundation and accelerate all intelligence across enterprises.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/huawei-upgrades-stellar-ai-wan-solution-to-drive-all-intelligence-across-industries-302884354.html

SOURCE Huawei

Continue Reading

Trending